MDT

100.26

+3%↑

147.57

+3.37%↑

VEEV

238.01

+7.61%↑

HQY

94.97

+1.71%↑

PHR.US

17.21

+0.53%↑

MDT

100.26

+3%↑

147.57

+3.37%↑

VEEV

238.01

+7.61%↑

HQY

94.97

+1.71%↑

PHR.US

17.21

+0.53%↑

MDT

100.26

+3%↑

147.57

+3.37%↑

VEEV

238.01

+7.61%↑

HQY

94.97

+1.71%↑

PHR.US

17.21

+0.53%↑

MDT

100.26

+3%↑

147.57

+3.37%↑

VEEV

238.01

+7.61%↑

HQY

94.97

+1.71%↑

PHR.US

17.21

+0.53%↑

MDT

100.26

+3%↑

147.57

+3.37%↑

VEEV

238.01

+7.61%↑

HQY

94.97

+1.71%↑

PHR.US

17.21

+0.53%↑

Home・Aktien・Avita Therapeutics Inc

Avita Therapeutics Inc

Geschlossen

3.42 -0.58

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

3.3

Max

3.45

Schlüsselkennzahlen
By Trading Economics
Einkommen	-3.3M -13M
Verkäufe	-1.4M 17M
Gewinnspanne	-77.289
Angestellte	260
EBITDA	-3.2M -11M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+22.48% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	12. Feb. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-16M 105M
Vorheriger Eröffnungskurs	4
Vorheriger Schlusskurs	3.42

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

8.83 / 9.77 Unterstützung & Widerstand

Avita Therapeutics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

6. Jan. 2026, 21:14 UTC

Wichtige Markttreiber

Ventyx Biosciences Gains on Report of Possible $1 Billion Eli Lilly Deal

6. Jan. 2026, 19:23 UTC

Akquisitionen, Fusionen, Übernahmen

OneStream to Go Private Through $6.4 Billion Hg Acquisition

6. Jan. 2026, 17:41 UTC

Wichtige Markttreiber

Blink Charging Shares Rise as EV Chargers Begin Accepting Cryptocurrency

6. Jan. 2026, 15:46 UTC

Akquisitionen, Fusionen, Übernahmen

Advent International Leads InPost Takeover Offer, Sky News Says

6. Jan. 2026, 15:37 UTC

Wichtige Markttreiber

Terrestrial Energy Shares Rise After DOE Agreement For Nuclear Plant Development

6. Jan. 2026, 23:46 UTC

Market Talk

Nikkei May Decline After Hitting Record High -- Market Talk

6. Jan. 2026, 23:35 UTC

Market Talk

Gold Edges Higher Amid Ongoing Geopolitical Tensions -- Market Talk

6. Jan. 2026, 23:19 UTC

Market Talk

Greatland 2Q Gold Output Strong, Sales Soft -- Market Talk

6. Jan. 2026, 22:53 UTC

Market Talk

WiseTech, REA and CAR Look Best Insulated From AI Threat -- Market Talk

6. Jan. 2026, 22:03 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6. Jan. 2026, 22:03 UTC

Akquisitionen, Fusionen, Übernahmen

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6. Jan. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

6. Jan. 2026, 21:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6. Jan. 2026, 21:12 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

6. Jan. 2026, 21:12 UTC

Market Talk

Commodity Demand Helps Canada Reduce Reliance on Trade With U.S. -- Market Talk

6. Jan. 2026, 20:59 UTC

Wichtige Markttreiber

Akquisitionen, Fusionen, Übernahmen

Ventyx Biosciences Gains on Report of Possible $1B Eli Lilly Deal

6. Jan. 2026, 20:40 UTC

Akquisitionen, Fusionen, Übernahmen

Acquisition of Ventyx Would Bring Lilly Into Emerging Category of Pills for Inflammation-Related Conditions -- WSJ

6. Jan. 2026, 20:40 UTC

Akquisitionen, Fusionen, Übernahmen

Eli Lilly Nears Deal for Biotech Ventyx -- WSJ

6. Jan. 2026, 20:40 UTC

Akquisitionen, Fusionen, Übernahmen

Deal Could Be Announced Imminently, Sources Say -- WSJ

6. Jan. 2026, 20:40 UTC

Akquisitionen, Fusionen, Übernahmen

Eli Lilly in Advanced Talks to Buy Ventyx Biosciences For Over $1B, Sources Say -- WSJ

6. Jan. 2026, 20:01 UTC

Market Talk

Oil Futures Give Back Post-Venezuela Incursion Gains -- Market Talk

6. Jan. 2026, 19:52 UTC

Market Talk

U.S. Natural Gas Falls Awaiting Colder Weather -- Market Talk

6. Jan. 2026, 19:46 UTC

Akquisitionen, Fusionen, Übernahmen

Under Armour Stock Rises After the 'Warren Buffet of Canada' Boosts Its Stake -- Barrons.com

6. Jan. 2026, 19:08 UTC

Akquisitionen, Fusionen, Übernahmen

OneStream to Go Private Through $6.4B Hg Acquisition

6. Jan. 2026, 18:28 UTC

Akquisitionen, Fusionen, Übernahmen

These Stocks Are Moving the Most Today: Sandisk, Nvidia, AMD, Palantir, OneStream, SoFi, Microchip, and More -- Barrons.com

6. Jan. 2026, 17:20 UTC

Market Talk

Ergebnisse

Financial Services Roundup: Market Talk

6. Jan. 2026, 17:20 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Health Care Roundup: Market Talk

6. Jan. 2026, 15:57 UTC

Market Talk

Crude Futures Ease Back From Early Gains -- Market Talk

6. Jan. 2026, 15:34 UTC

Market Talk

Ergebnisse

Bank of Montreal Expects to Exit 2027 With ROE Hitting 15% Target -- Market Talk

6. Jan. 2026, 15:27 UTC

Market Talk

German Inflation Won't Fall Much Further in 2026 -- Market Talk

Peer-Vergleich

Kursveränderung

Avita Therapeutics Inc Prognose

Kursziel

By TipRanks

22.48% Vorteil

12-Monats-Prognose

Durchschnitt 4.25 USD 22.48%

Hoch 5.5 USD

Tief 3 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Avita Therapeutics Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

3 ratings

Buy

Halten

Sell

Basierend auf 3 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Avita Therapeutics Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

8.83 / 9.77Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.